Identification of a clinically relevant androgen-dependent gene signature in prostate cancer
about
RhoA as a mediator of clinically relevant androgen action in prostate cancer cellsTargeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?Transcriptome analysis of the dihydrotestosterone-exposed fetal rat gubernaculum identifies common androgen and insulin-like 3 targetsAndrogen receptor and its splice variants in prostate cancerThe prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation AnalysisAndrogen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expressionAndrogen-responsive serum response factor target genes regulate prostate cancer cell migration.Molecular signatures in urologic tumors.Genetic variants in RhoA and ROCK1 genes are associated with the development, progression and prognosis of prostate cancerThe role of transcription factors in prostate cancer and potential for future RNA interference therapy.Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?Relationship between serum response factor and androgen receptor in prostate cancer.Sex-specific gene-environment interactions underlying ASD-like behaviors.A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer.Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients.High frequency of the SDK1:AMACR fusion transcript in Chinese prostate cancer.Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene.
P2860
Q24618899-9635F852-AA39-4037-90FF-875708687CABQ33775717-5D76E6A3-D10F-4C7A-ACB4-8823FCF728A6Q33826110-0C395FC5-F476-43AD-8554-1E8134B88D51Q34199684-E1C1A090-7550-4927-810C-3F939472AF26Q36294460-014132D4-2514-4D0A-BF64-AFDE39FE1ED1Q36628603-0F3560D8-37E7-48D3-A6BD-DF51CF3384F7Q36807948-F63A9A49-60DF-497E-A28C-0F04EBC909EDQ37065350-636E30D2-7CEE-452E-B9AE-4C99AB87AC3EQ37225156-1CA73761-466F-4F4C-8FB3-126905833A7DQ37745990-068E3FDA-9CB7-4EC9-8D34-819C15F87B52Q38198726-5BD4A4CB-8889-4B91-8FCE-C92936BB8CEBQ38318104-96A17745-7AB0-4C01-AF9F-B45E66862EA1Q38845729-20FB39ED-F3DA-4BB4-A76A-AEE099E48B10Q39003361-44A10AA6-E124-42F0-8FC2-C98D4453D72CQ41691950-41D088F8-823C-4B41-99F9-A8F41DF345FAQ42122998-71E64BEF-61C6-4D7B-B227-4C2C13495991Q43156871-01ABF250-1347-4836-8A4B-5EA06291DE5DQ53779715-0C27A4B0-E0BC-42D4-B636-88DA8D3101C5
P2860
Identification of a clinically relevant androgen-dependent gene signature in prostate cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of a clinically ...... e signature in prostate cancer
@ast
Identification of a clinically ...... e signature in prostate cancer
@en
type
label
Identification of a clinically ...... e signature in prostate cancer
@ast
Identification of a clinically ...... e signature in prostate cancer
@en
prefLabel
Identification of a clinically ...... e signature in prostate cancer
@ast
Identification of a clinically ...... e signature in prostate cancer
@en
P2093
P2860
P1433
P1476
Identification of a clinically ...... e signature in prostate cancer
@en
P2093
Donald J Tindall
Hannelore V Heemers
Karla V Ballman
Kelly Duncan
Kevin M Regan
Lucy J Schmidt
S Keith Anderson
P2860
P304
P356
10.1158/0008-5472.CAN-10-2512
P407
P50
P577
2011-02-15T00:00:00Z